People: ARIAD Pharmaceuticals Inc (ARIA.O)
19.57USD
24 May 2013
$0.13 (+0.67%)
$19.44
$19.43
$19.75
$19.09
2,652,526
3,129,720
$25.40
$15.13
Dodion, Pierre
Brief Biography
Dr. Pierre F. Dodion, M.D., M.B.A., is Senior Vice President - Corporate Development and Operations of Ariad Pharmaceuticals, Inc. since February 2012. He has been Senior Vice President, Corporate Development from July 2010 to January 2012. Previously, he served as Senior Vice President and Chief Medical Officer from April 2008 to June 2010 and as Senior Vice President, Oncology from June 2007 to April 2008. From 2006 to 2007, Dr. Dodion served as Executive Director, Oncology at Pfizer Inc. From 2002 to 2006, he held senior positions at Novartis in the Oncology Business Unit, most recently as Executive Director, Global Strategy and Global Marketing. From 1997 to 2002, Dr. Dodion served as Medical Director and later as Senior Medical Director at Aventis. Prior to Aventis, he held medical and scientific positions at UBC S.A. and Roche Pharmaceuticals. Previously, he held positions at Institut Jules Bordet at the Free University of Brussels and the National Cancer Institute. Dr. Dodion received his M.D. degree from the Free University of Brussels in Belgium and his M.B.A. degree from St. Joseph University in Philadelphia, Pennsylvania.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 432,000 | -- | 104,883 | 558,946 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Harvey Berger |
3,859,660 |
Edward Fitzgerald |
1,295,370 |
Raymond Keane |
-- |
David Berstein |
744,434 |
Daniel Bollag |
779,877 |
Maria Cantor |
-- |

